Johnny's in the Basement, Mixin' up the Medicine: Review of Angell, Avorn, and Daemmrich on the Modern Pharmaceutical Predicament

Autor: Mirowski, Philip

Publikováno v: Social Studies of Science, 2007 Apr 01. 37(2), 311-327.

Externí odkaz: https://www.jstor.org/stable/25474519

Pursuing Value-Based Prices for Drugs : A Comprehensive Comparison of State Prescription Drug–Pricing Boards

Autor: BENDICKSEN, LIAM, ROME, BENJAMIN N., AVORN, JERRY, KESSELHEIM, AARON S.

Publikováno v: The Milbank Quarterly, 2021 Dec 01. 99(4), 1162-1197.

Externí odkaz: https://www.jstor.org/stable/48646342

Drug interaction resulting in massive chest wall hematoma in a patient on therapeutic anticoagulation... 1. Gurwitz JH, Avorn J, Ross-Degnan D, Choodnovskiy I, Ansell J. Aging and the anticoagulant response to warfarin therapy. Ann Intern Med 1992;116:901-4.

Autor: Rangappa, Pradeep¹ drpradeepr@aol.com, Murthy, Tejaswini Arunachala¹, Jacob, Ipe¹

Publikováno v: Indian Journal of Critical Care Medicine. Apr2015, Vol. 19 Issue 4, p246-247. 2p.

Accounting for US public funding in drug development : how can we better balance access, affordability, and innovation?

Autor: Sarpatwari, Ameet, Avorn, Jerry, Kesselheim, Aaron S

Publikováno v: BMJ: British Medical Journal, 2020 Oct 01. 371, 1-4.

Externí odkaz: https://www.jstor.org/stable/27239492

Government Funding for the Development of Enzalutamide.

Autor: Gyawali B; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Department of Oncology, Queen's University, Kingston, Ontario, Canada.; Department of Public Health Sciences, Division of Cancer Care and Epidemiology, Queen's University, Kingston, Ontario, Canada., Jung EH; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Mooney H; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Avorn J; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Kesselheim AS; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Publikováno v: JAMA oncology [JAMA Oncol] 2024 Dec 19. Date of Electronic Publication: 2024 Dec 19.